All posts by: Michael Zand

About Michael Zand

With ‘breakthrough’ status and a handy nickname, BioMarin plots … – Endpoints News

Continue reading

2017-10-27 NEWS

Pharmacy Practice News

With ‘breakthrough’ status and a handy nickname, BioMarin plots …
Endpoints News
The FDA has handed out its breakthrough therapy designation for BioMarin’s closely-watched gene therapy drug BMN 270 for hemophilia A. In their Q3 call on …
FDA Gives Designations to Hemophilia Gene Therapies – Pharmacy …Pharmacy Practice News
BioMarin’s Gene Therapy for Hemophilia A Continues to ImpressRare Disease Report (blog)
Hemophilia Gene Therapy Market Pipeline Analysis 2016 to 2021 …Medgadget (blog)
pharmaphorum –Healio
all 7 news articles »